Onalespib

DB06306InvestigationalSmall molecule

Investigated for use/treatment in cancer/tumors (unspecified).

Chemical structure of Onalespib
Primary indication
Investigated for use/treatment in cancer/tumors (unspecified).Curator reviewed
Formula / weight
C24H31N3O3 · 409.53 g/mol (avg)
Code names
AT-13387 · ATI-13387X

Resolves to

Compound
UNIIQ7Y33N57ZZCAS912999-49-6ChEMBLCHEMBL1214827ChEBI140592
Structure
InChIKeyIFRGXKKQHBVPCQ-UHFFFAOYSA-NSMILESCC(C)C1=CC(C(=O)N2CC3=CC=C(CN4CCN(C)CC4)C=C3C2)=C(O)C=C1O
Targets
P07900HSP90AA1

What you can answer from here — as of October 07, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
12Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Onalespib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In